Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03501 |
| Species: | Homo sapiens |
| Position : | chr9:133401000-133404500 |
| Year: | 2016 |
| Title: | BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast carcinoma |
| PMID: | 27803105 |
| MONDO: | MONDO:0006120 |
| Tissue: | Breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | ZR-75-1 |
| CVCL ID: | CVCL_0588 |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000646 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, Chromatin interaction assay |
| High Throughput Method: | ChIP-seq, RNA-seq, 3C |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR |
| Target gene : | ALDH1A1 |
| TF name : | BRD4 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|